ONCOLOGY

Journal Title

ONCOLOGY

ONCOLOGY-BASEL

ISSN / eISSN

0030-2414 / 1423-0232

Aims and Scope

Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.

Subject Area

ONCOLOGY

CiteScore

6.00 View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Oncology	Q2	#129/366
Medicine - Cancer Research	Q2	#104/214

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
ONCOLOGY - SCIE	Q3

H-index

92

Country/Area of Publication

SWITZERLAND

Publisher

S. Karger AG

Publication Frequency

Bimonthly

Year Publication Started

1967

Annual Article Volume

82

Open Access

NO

Contact

KARGER, ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009